FDA to Hold Public Meeting on Talc
Posted on Wednesday, January 15th, 2020
FDA will discuss testing methods, terminology, and other issues related to talc and asbestos.
Wednesday, January 15, 2020 – The U.S. Food and Drug Administration will hold a public meeting regarding the testing methods for asbestos in talc and other cosmetic products February 4, 2020. The meeting will be available by webcast for those unable to attend the Silver Springs, Maryland venue.
The FDA will hold a public meeting, available online, regarding talc and other cosmetic products. The purpose of this public meeting is to obtain and discuss information and scientific data regarding testing methodologies, terminology, and the criteria needed to measure and characterize asbestos and other elongate mineral particles (EMPs) that have been found in some talc and cosmetic consumer products.
Among the topics discussed will be preliminary recommendations by a federal interagency working group to establish uniform terminology and definitions of EMPs, including asbestos, that are currently of concern to health and wellbeing, as well as information regarding methods, criteria, and terminology to be used in the development of standardized testing of asbestos.
The meeting will be held Feb. 4, 2020 in the great room at the FDA White Oaks Campus, 10903 New Hampshire Ave., Building 31, Silver Spring, MD 20993 from 8:30 a.m. until 5 p.m.
If you would like to attend this meeting, either online or in person, please register here. For general questions about the meeting or to request special accommodations due to a disability, contact Denise Hodge at Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr. (HFS-125), College Park, MD 20704. You can also call 301-796-7739 or email firstname.lastname@example.org.
January 17, 2020: Deadline to request special accommodations due to disability
January 17, 2020: Deadline for requests to make an oral presentation
January 28, 2020: Deadline for early registration
February 4, 2020: Public Meeting
March 4, 2020: Deadline to submit electronic or written comments into the docket